Daily White kwao krua dietary supplement alleviates LDL oxidative susceptibility, plasma LDL level and improves vasculature in a hypercholesterolemia rabbit model

Spagnoli, 2007, Role of inflammation in atherosclerosis, J Nucl Med, 48, 1800, 10.2967/jnumed.107.038661 Honjo, 2008, Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells, Endothelium, 15, 137, 10.1080/10623320802125433 Gu, 1998, Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor–deficient mice, Mol Cell, 2, 275, 10.1016/S1097-2765(00)80139-2 Quehenberger, 2005, Thematic review series: the immune system and atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis, JLR (J Lipid Res), 46, 1582, 10.1194/jlr.R500008-JLR200 Gong, 2007, Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells, Genome Biol, 8, R149, 10.1186/gb-2007-8-7-r149 Rohman, 2015, Analysis of curcumin in curcuma longa and Curcuma xanthorriza using FTIR spectroscopy and chemometrics, Res J Med Plant, 9, 179, 10.3923/rjmp.2015.179.186 Ramı́rez-Tortosa, 1999, Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis, Atherosclerosis, 147, 371, 10.1016/S0021-9150(99)00207-5 Quiles José, 2002, Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits, Arterioscler Thromb Vasc Biol, 22, 1225, 10.1161/01.ATV.0000020676.11586.F2 Olszanecki, 2005, Effect of curcumin on atherosclerosis in apoE/LDLR - double knockout mice, J Physiol Pharmacol : An Off. J. Pol. Physiol. Soc., 56, 627 Sanvarinda, 2003, 87 Cherdshewasart, 2007, Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata, J Pharmaceut Biomed Anal, 43, 428, 10.1016/j.jpba.2006.07.013 Lee, 2017, Determination of miroestrol and isomiroestrol from pueraria mirifica (white kwao krua) in dietary supplements by LC–MS-MS and LC–Q-orbitrap/MS, J Chromatogr Sci, 55, 214 Cho, 2014, Flavonoids from Pueraria mirifica roots and quantitative analysis using HPLC, Food Science and Biotechnology, 23, 1815, 10.1007/s10068-014-0248-4 Udomsin, 2015, Chromene stability: the most potent estrogenic compounds in White Kwao Krua (Pueraria candollei var mirifica) crude extract, Journal of Functional Foods, 19, 269, 10.1016/j.jff.2015.09.036 Shimokawa, 2013, Quantitative analysis of miroestrol and kwakhurin for standardisation of Thai miracle herb ’Kwao Keur’ (Pueraria mirifica) and establishment of simple isolation procedure for highly estrogenic miroestrol and deoxymiroestrol, Nat Prod Res, 27, 371, 10.1080/14786419.2012.695370 Chansakaow, 2000, Identification of deoxymiroestrol as the actual rejuvenating principle of “kwao keur”, pueraria mirifica. The known miroestrol may Be an artifact, J Nat Prod, 63, 173, 10.1021/np990547v Chansakaow, 2000, Isoflavonoids from pueraria mirifica and their estrogenic activity, Planta Med, 66, 572, 10.1055/s-2000-8603 Lawanprasert, 2006, Effects of Pueraria mirifica subchronic exposure on hepatic cytochrome P450 in rats fed with normal and high -cholesterol diets, Thai Journal of Pharmacology, 28, 21 Miller, 1995, Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial, J Am Med Assoc, 273, 199, 10.1001/jama.1995.03520270033028 Okamura, 2009, Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes, Tohoku J Exp Med, 216, 341, 10.1620/tjem.216.341 Manonai, 2008, Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women, Menopause, 15 Wattanapitayakul, 2005, Effects of Pueraria mirifica on vascular function of ovariectomized rabbits, Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 88, S21 Piyachaturawat, 1996, Choleretic effect of curcuma comosa rhizome extracts in rats, Int J Pharmacogn, 34, 174, 10.1076/phbi.34.3.174.13204 Redgrave, 1975, Separation of plasma lipoproteins by density-gradient ultracentrifugation, Anal Biochem, 65, 42, 10.1016/0003-2697(75)90488-1 Goldstein a, 1977, The low-density lipoprotein pathway and its relation to atherosclerosis, Annu Rev Biochem, 46, 897, 10.1146/annurev.bi.46.070177.004341 Henriksen, 1979, Injury to human endothelial cells in culture induced by low density lipoproteins, Scand J Clin Lab Investig, 39, 361, 10.3109/00365517909106120 Henriksen, 1981, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins, Proc Natl Acad Sci U S A, 78, 6499, 10.1073/pnas.78.10.6499 Abe, 1998, Reactive oxygen species as mediators of signal transduction in cardiovascular disease, Trends Cardiovasc Med, 8, 59, 10.1016/S1050-1738(97)00133-3 Sies, 2005, Nutritional, dietary and postprandial oxidative stress, J Nutr, 135, 969 Murphy, 2008, Cholesterol, reactive oxygen species, and the formation of biologically active mediators, J Biol Chem, 283, 15521, 10.1074/jbc.R700049200 Witztum, 1993, Susceptibility of low-density lipoprotein to oxidative modification, Am J Med, 94, 347, 10.1016/0002-9343(93)90143-D Cui, 2001, Non–high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality, JAMA Internal Medicine, 161, 1413 Witztum, 1991, Role of oxidized low density lipoprotein in atherogenesis, J Clin Invest, 88, 1785, 10.1172/JCI115499 Parthasarathy, 1992, The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis, Annu Rev Med, 43, 219, 10.1146/annurev.me.43.020192.001251 Schwab, 2000, Dietary cholesterol increases the susceptibility of low density lipoprotein to oxidative modification, Atherosclerosis, 149, 83, 10.1016/S0021-9150(99)00310-X Lin, 2002, Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages, J Cell Biochem, 86, 258, 10.1002/jcb.10210 Mertens, 2001, Oxidized LDL and HDL: antagonists in atherothrombosis, Faseb J, 15, 2073, 10.1096/fj.01-0273rev Jacobs, 1990, Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta, Br J Pharmacol, 100, 21, 10.1111/j.1476-5381.1990.tb12045.x Zeiher, 1991, Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis, Circulation, 83, 391, 10.1161/01.CIR.83.2.391 Kolodgie, 1990, Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits, Circ Res, 66, 1112, 10.1161/01.RES.66.4.1112 Böger, 1994, Long term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats, Cardiovasc Res, 28, 494, 10.1093/cvr/28.4.494 Steinbrecher, 1988, Role of superoxide in endothelial-cell modification of low-density lipoproteins, Biochim Biophys Acta Lipids Lipid Metabol, 959, 20, 10.1016/0005-2760(88)90145-2 Davignon, 2004, Role of endothelial dysfunction in atherosclerosis, Circulation, 109 Stoll, 2006, Inflammation and atherosclerosis, Stroke, 37, 1923, 10.1161/01.STR.0000226901.34927.10 Egashira, 1994, Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia, Circulation, 89, 2519, 10.1161/01.CIR.89.6.2519 Levine Glenn, 1996, Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease, Circulation, 93, 1107, 10.1161/01.CIR.93.6.1107 Shore, 1976, Rabbits as a model for the study of hyperlipoproteinemia and atherosclerosis, 123 Bocan, 1993, The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation, Atherosclerosis, 102, 9, 10.1016/0021-9150(93)90080-E Srisawat, 2003, Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fed rabbits, Clin Exp Pharmacol Physiol, 30, 405, 10.1046/j.1440-1681.2003.03850.x Chumark, 2008, The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves, J Ethnopharmacol, 116, 439, 10.1016/j.jep.2007.12.010 Bittencourt, 2015, Statin effects on atherosclerotic plaques: regression or healing?, BMC Med, 13, 260, 10.1186/s12916-015-0499-9 Conde, 1999, Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the Guinea pig: atorvastatin versus simvastatin, Biochem Pharmacol, 58, 1209, 10.1016/S0006-2952(99)00203-8 Oranje, 2001, Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients, Clin Chim Acta, 311, 91, 10.1016/S0009-8981(01)00549-6 Alwi, 2008, The effect of curcumin on lipid level in patients with acute coronary syndrome, Acta medica Indonesiana, 40, 201 Qin, 2017, Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials, Nutr J, 16, 68, 10.1186/s12937-017-0293-y Malaivijitnond, 2012, Medical applications of phytoestrogens from the Thai herb Pueraria mirifica, Front Med, 6, 8, 10.1007/s11684-012-0184-8 John, 1986, A chemical investigation of pueraria mirifica roots, Z Naturforsch C Biosci, 41, 403 John, 1988, Coumestans from the roots of pueraria mirifica, Z Naturforsch C Biosci, 43, 5 John, 1989, Minor isoflavones from the roots of pueraria mirifica, Z Naturforsch C Biosci, 44, 724 Malaivijitnond, 2004, Different effects of Pueraria mirifica, a herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats, J Pharmacol Sci, 96, 428, 10.1254/jphs.FPJ04029X J, 1961, The effect OF miroestrol ON vaginal cornification, pituitary function and pregnancy IN the rat, J Endocrinol, 22, 293, 10.1677/joe.0.0220293 Cain, 1960, Mirœstrol: an œstrogen from the plant pueraria mirifica, Nature, 188, 774, 10.1038/188774a0 Manonai, 2008, Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women, Menopause, 15, 530, 10.1097/gme.0b013e31815c5fd8 Zhan, 2005, Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile, Am J Clin Nutr, 81, 397, 10.1093/ajcn.81.2.397